The bmx mouse provides the first preclinical mouse model of BMD featuring CRISPR-induced deletion of endogenous dystrophin exons 45–47, which models the most common BMD patient mutation and is associated with more severe skeletal muscle pathology and cardiac outcomes.19 Here, BMX is linked to Becker muscular dystrophy.